Floatz logo

PANITUMUMAB

Cardiac Surgery

Parthasarathy Thirumalamonoclonal_antibodyN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Cardiac Surgery cohort.

Asset / SponsorPhaseRating
PROTAMINE
University Hospital, Strasbourg, France
Phase 4BB
ROPIVACAINE
University of British Columbia
Phase 3BB
HEPARIN
University Hospital, Strasbourg, France
Phase 4BB
Gentamycin
Innocoll
Phase 3B
DEXAMETHASONE
Instituto do Coracao
Phase 3B

View all 9 →

Same molecule, other indications

PANITUMUMAB is also rated in:

neoplasmDormant
BBB
Indicative ·
73 / 100
View asset →
colorectal cancerDormant
BB
Indicative ·
70 / 100
View asset →
malignant pancreatic neoplasmDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →